Effect of 7-O-β-D-glucopyranosylchrysin and its aglycone chrysin isolated from Podocytisus caramanicus on estrogen receptor α transcriptional activity

Planta Medica

Volumn 73, Issue 14, 2007, Pages 1447-1451

  Berthier, Alexandre ^a   Girard, Corinne ^b   Grandvuillemin, Aurélie ^b   Muyard, Frédéric ^b   Skaltsounis, Alexios Leandros ^c   Jouvenot, Michèle ^a   Delage Mourroux, Régis ^a,d  

^a IFR 133   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c UNIVERSITY OF ATHENS   (Greece)

^d IFR 133   (France)

Author keywords

7 O D glucopyranosylchrysin; Chrysin; Estrogen receptor ; Fabaceae; Podocytisus caramanicus Boiss. Heldr.

Indexed keywords

7 O BETA GLUCOPYRANOSYLCHRYSIN; AGLYCONE CHRYSIN; CHRYSIN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; PLANT EXTRACT; PODOCYTISUS CARAMANICUS EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN MCF 7; DRUG EFFICACY; ESTROGEN ACTIVITY; FEMALE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEGUME; MEDICINAL PLANT; PODOCYTISUS CARAMANICUS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FABACEAE; FLAVONOIDS; GLUCOSIDES; HUMANS; MOLECULAR STRUCTURE; TRANSCRIPTION, GENETIC;

FABACEAE;

EID: 36949013671     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-990248     Document Type: Article

References (11)

1. Diel P. Tissue-specific estrogenic response and molecular mechanisms. Toxicol Lett 2002; 127: 217-24.
2. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835-9.
3. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001; 29: 2905-19.
4. Mc Ewen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999; 20: 279-307.
5. Dhandapani KM, Brann DW. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 2002; 67: 1379-85.
6. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama 2002; 288: 321-33.
7. De Cremoux P, Tran-Perennou C, Brockdorff BL, Boudou E, Brunner N, Magdelenat H et al. Validation of real time RT-PCR for analysisof human breast cancer cell lines resistant or sensitive to treatment with antiestrogens. Endocr Relat Cancer 2003; 10: 409-18.
8. Lazennec G, Alcorn JL, Katzenellenbogen BS. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. Mol Endocrinol 1999; 13: 969-80.
9. De Rosa S, De Stefano S. Chrysin 7-gentiobioside from the flowers of Spartium junceum. Phytochemistry 1983; 22: 2323-4.
10. Tutin TG. Flora Europea; 2nd edition Cambridge: Cambridge University Press; 1968
11. Yuan L, Wagatsuma C, Yoshida M, Miura T, Mukoda T, Fujii H et al. Inhibition of human breast cancer growth by GCPTM (genistein combined polysaccharide) in xenogeneic athymic mice: involvement of genistein biotransformation by β-glucuronidase from tumor tissues. Mutat Res 2003; 523-524: 55-62.